Su Jin Kim

Su Jin Kim is a litigation attorney at Morgan, Lewis & Bockius LLP, where she was promoted to partner in 2022. Her practice primarily focuses on complex commercial litigation, including disputes related to mergers and acquisitions (M&A), indemnification, contract disputes, and business torts such such as fraud and unfair trade practices. She counsels clients across diverse industries, including healthcare, consumer goods, financial services, pharmaceutical, energy, and medical devices.

According to available tracking data, Ms. Kim has one recorded appearance in patent litigation, serving as plaintiff's counsel in Embody Inc. et al. v. LifeNet Health. Her broader litigation experience, as detailed in her firm profile, encompasses trial and appellate experience at both federal and state court levels, as well as alternative dispute resolution proceedings.

A notable recent outcome includes her representation of Defendants Zimmer Biomet Holdings Inc. and Embody Inc. in an earnout dispute, Timothy H. Meyers v. Zimmer Biomet Holdings, Inc. and Embody, Inc., before the Delaware Court of Chancery. In May 2026, Morgan Lewis secured a significant win for their clients, with the court largely dismissing claims against Zimmer Biomet. While her firm profile does not specifically highlight Patent Trial and Appeal Board (PTAB) or inter partes review (IPR) experience, her focus on complex litigation spans various commercial disputes.

Ms. Kim earned her J.D., cum laude, from Georgetown University Law Center in 2009. She also holds a B.S. in Economics and a B.A. in International Studies, both cum laude, from the University of Pennsylvania (2004). Prior to her legal career, she worked as an investment banking analyst in Hong Kong. She is admitted to practice in New Jersey, New York, and Pennsylvania.